MSB11022 in moderately to severely active rheumatoid arthritis

Update Il y a 4 ans
Reference: EUCTR2016-002852-26

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to evaluate the safety profile of MSB11022 compared to reference product in patients with moderately to severely active rheumatoid arthritis (RA) up to Week 52.


Inclusion criteria

  • Moderately to severely active rheumatoid arthritis